| abstract |
The present invention provides an isolated population of chondrocyte precursor cells wherein 1 % or less of the cells express Oct4, Nanog and/or TRA-1-60, 7 % or less of the cells express no collagen II, collagen X, CD105 or Stro-1 and 85 % or more of the cells express CBFA1, methods for preparing such cells and uses of chondrocyte cells derived from said precursor cells. |